GT Biopharma is generating novel immuno-oncology biopharmaceutical drugs targeting cancers such as acute lymphocytic leukemia, non-Hodgkin's lymphoma, acute myeloid leukemia, and multiple solid tumors by leveraging their proprietary NK cell engager (TriKE™) platform technology.

Biotechnology

GTBiopharma

GTBiopharma's headquarters in Beverly Hills, CA, United States

Michael Breen

Alan L. Urban

Stacy Herb

Gavin Choy

Jeffrey S. Miller

Manu Ohri

Lisa A. Haile

Arjun V Balar

Philip Werthman

Samir Taneja

GTBiopharma's Leadership Team includes Michael Handelman and 6 others.

Leadership Team

About

People

Gavin Choy

Jeffrey S. Miller

Stacy Herb